Reuters logo
BRIEF-Zynerba Pharmaceuticals initiates ZYN001 phase 1 clinical program
June 26, 2017 / 11:45 AM / 5 months ago

BRIEF-Zynerba Pharmaceuticals initiates ZYN001 phase 1 clinical program

June 26 (Reuters) - Zynerba Pharmaceuticals Inc

* Zynerba Pharmaceuticals initiates ZYN001 phase 1 clinical program

* Zynerba Pharmaceuticals Inc - Study includes single rising dose and multiple rising dose evaluations for ZYN001

* Zynerba pharmaceuticals - phase 1 results will inform potential phase 2 studies in patients with fibromyalgia, neuropathic pain, planned to start in 2h17 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below